Dabis F - Search Results

1

Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99.

Thiébaut R, Dequae-Merchadou L, Ekouevi DK, Mercié P, Malvy D, Neau D, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitane (GECSA). Thiébaut R, et al. Among authors: dabis f. HIV Med. 2001 Apr;2(2):84-8. doi: 10.1046/j.1468-1293.2001.00057.x. HIV Med. 2001. PMID: 11737383 Free article.

2

Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Saillour F, Bernard N, Dequae-Merchadou L, Marimoutou C, Journot V, Dabis F. Saillour F, et al. Among authors: dabis f. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Feb 1;17(2):171-8. doi: 10.1097/00042560-199802010-00012. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9473020

3

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Chêne G, Binquet C, Moreau JF, Neau D, Pellegrin I, Malvy D, Ceccaldi J, Lacoste D, Dabis F. Chêne G, et al. Among authors: dabis f. AIDS. 1998 Dec 3;12(17):2313-20. doi: 10.1097/00002030-199817000-00013. AIDS. 1998. PMID: 9863874 Clinical Trial.

4

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA).

Savès M, Vandentorren S, Daucourt V, Marimoutou C, Dupon M, Couzigou P, Bernard N, Mercié P, Dabis F. Savès M, et al. Among authors: dabis f. AIDS. 1999 Dec 3;13(17):F115-21. doi: 10.1097/00002030-199912030-00002. AIDS. 1999. PMID: 10597772

5

Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Thiébaut R, Dabis F, Malvy D, Jacqmin-Gadda H, Mercié P, ValentinVD. Thiébaut R, et al. Among authors: dabis f. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):261-5. doi: 10.1097/00126334-200003010-00009. J Acquir Immune Defic Syndr. 2000. PMID: 10839662

6

Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).

Thiébaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercié P, Dabis F, Chêne G. Thiébaut R, et al. Among authors: dabis f. AIDS. 2000 May 26;14(8):971-8. doi: 10.1097/00002030-200005260-00008. AIDS. 2000. PMID: 10853978 Clinical Trial.

7

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.

Thiébaut R, Daucourt V, Mercié P, Ekouévi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F. Thiébaut R, et al. Among authors: dabis f. Clin Infect Dis. 2000 Dec;31(6):1482-7. doi: 10.1086/317477. Epub 2000 Nov 29. Clin Infect Dis. 2000. PMID: 11096016

8

Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.

Marimoutou C, Chêne G, Mercié P, Neau D, Farbos S, Morlat P, Ceccaldi J, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Marimoutou C, et al. Among authors: dabis f. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):161-7. doi: 10.1097/00126334-200106010-00011. J Acquir Immune Defic Syndr. 2001. PMID: 11404538 Clinical Trial.

9

Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997.

Vandentorren S, Mercié P, Marimoutou C, Neau D, Malvy D, Farbos S, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Vandentorren S, et al. Among authors: dabis f. Eur J Epidemiol. 2001;17(1):7-10. doi: 10.1023/a:1010972410865. Eur J Epidemiol. 2001. PMID: 11523579

10

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, Decoin M, Djossou F, Beylot J, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Bonnet F, et al. Among authors: dabis f. HIV Med. 2002 Jul;3(3):195-9. doi: 10.1046/j.1468-1293.2002.00117.x. HIV Med. 2002. PMID: 12139658 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters